De novo cancer-related mortality after solid organ transplantation in England: the EpCOT study.
Long-term cancer risk is substantially elevated in organ transplant recipients, informing tailored surveillance strategies.
This EpCOT population-based registry study of England quantifies cancer-related mortality in solid organ transplant recipients, demonstrating substantially elevated risk especially for lymphoma and skin cancers. The findings inform cancer surveillance prioritization strategies for transplant recipients on chronic immunosuppression.
What the study was
- Study design
- Population-based registry cohort study
- Population
- Solid organ transplant recipients in England (EpCOT registry)
- Category
- Public Health
- Maturity
- Validated
- Journal
- British journal of cancer
Why it surfaced
Br J Cancer; EpCOT England population registry; cancer mortality patterns post-transplant inform surveillance guidelines; matched T1 on lymphoma.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.